This aberrant expression of GAL-7 is likely triggered by DNA hypomethylation [69,70] or activation of signaling pathways associated with tumor progression, including gain-of-function mutations in the p53 gene [71,72]. The gene discussed is LGALS7; the disease is neoplasm.